NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Yes, and that is exactly one of the reasons the RWE reforms are so useful. The regulatory agencies and insurance systems including governmental can rely on non-trial, less formal, RWE to expand coverage and labels. And that stuff is so new, so people keep assuming the old world trial notions are necessary, but over time I believe we will see, or it might be not all that visible to us given the process, but we will likely see access to new drugs expanding broadly and more rapidly than before. It may just happen though, without a lot of commotion and fanfare.

So it’s a very exciting time. But some of it doesn’t make for exciting posts, because it will happen off-stage and perhaps not entirely visible to everyone initially. It will just be events. Suddenly a drug will be available for another condition or disease.